Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes
Ottavio Giampietro, Chiara Giampietro, Luca Della Bartola, Maria Chiara Masoni, Elena MatteucciDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyBackground: Sitagliptin has been proven to be effective and safe as add-on to insulin in adult patients with type 2 diabetes...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-02-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/sitagliptin-as-add-on-therapy-in-insulin-deficiency-biomarkers-of-ther-a12217 |